Medical Marijuana for Cancer in Washington State

Cancer is one of Washington State's explicitly named qualifying conditions for medical marijuana. For patients managing cancer symptoms — whether from the disease itself or from treatments like chemotherapy and radiation — medical cannabis offers meaningful symptom relief that many conventional drugs don't provide as effectively.

Cancer qualifies for Washington medical marijuana

Washington's medical cannabis statute (RCW 69.51A) lists cancer as a qualifying condition by name. Any cancer diagnosis — regardless of stage, type, or current treatment status — satisfies the qualifying condition requirement. You do not need to be in active treatment or have a specific severity threshold. If you have a cancer diagnosis, you qualify.

Related conditions that also qualify independently include:

• Chronic pain from cancer or cancer treatment
• Nausea and vomiting from chemotherapy (also named in statute)
• Cachexia (wasting syndrome) — a common complication of advanced cancer
• Intractable pain or terminal illness

How cannabis helps cancer patients

Cannabis doesn't treat cancer itself — but it can significantly improve quality of life during treatment and recovery. Evidence-backed uses include:

• Chemotherapy-induced nausea and vomiting (CINV) — one of the most well-documented medical cannabis applications. Synthetic cannabinoids (dronabinol, nabilone) are FDA-approved for CINV; natural cannabis is effective for many patients who don't respond to FDA-approved antiemetics.
• Pain management — cancer pain can be neuropathic, inflammatory, or both. Cannabis's dual mechanism (CB1 for neural pain, anti-inflammatory for tissue pain) makes it particularly versatile for cancer-related pain. Many patients reduce opioid use after starting cannabis.
• Appetite stimulation — THC is a well-established appetite stimulant. For patients experiencing cancer-related weight loss, improved appetite and caloric intake can be clinically significant.
• Sleep and anxiety — cancer treatment often disrupts sleep and triggers anxiety. Cannabis addresses both, often simultaneously.
• Neuropathy — chemotherapy-induced peripheral neuropathy (CIPN) is common and often inadequately treated with standard drugs. Cannabis, particularly high-CBD topicals and balanced oral products, may reduce CIPN symptoms.

What cancer patients should know about dosing

Cancer patients often need more individualized dosing than the typical medical cannabis patient. Treatment-phase needs may differ significantly from post-treatment needs. Your Green Wellness provider will discuss:

• Whether you're in active treatment (chemo, radiation) or post-treatment/maintenance
• Which symptoms are primary (nausea vs. pain vs. sleep vs. appetite)
• Your current medications (some cannabinoid-drug interactions exist — particularly with certain chemotherapy agents metabolized by CYP450 enzymes)
• Product forms appropriate for your situation (edibles may be difficult during CINV; vaporization or tinctures may be preferred)

Getting your authorization

If you have a cancer diagnosis, your Green Wellness evaluation is straightforward. Bringing documentation of your diagnosis (a letter from your oncologist, a recent medical record, or your cancer center's patient portal printout) helps but isn't required. Your provider will review your situation and issue an authorization the same day if appropriate.

Green Wellness offers same-day appointments at all four locations. Telehealth is available for renewals and, in some cases, for patients who can't travel during treatment.

Book your cancer evaluation — $175 →